BETTER THERAPEUTICS INC's ticker is and the CUSIP is 08773T104. A total of 18 filers reported holding BETTER THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.07 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $22,608 | -53.7% | 58,600 | +29.6% | 0.00% | – |
| Q2 2023 | $48,816 | +48.3% | 45,200 | 0.0% | 0.00% | – |
| Q1 2023 | $32,906 | -67.5% | 45,200 | -50.0% | 0.00% | – |
| Q4 2022 | $101,248 | +26.6% | 90,400 | +100.0% | 0.00% | – |
| Q3 2022 | $80,000 | +12.7% | 45,200 | 0.0% | 0.00% | – |
| Q2 2022 | $71,000 | +14.5% | 45,200 | +239.2% | 0.00% | – |
| Q4 2021 | $62,000 | – | 13,327 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FARALLON CAPITAL MANAGEMENT LLC | 1,000,000 | $1,560,000 | 0.01% |
| Tower Research Capital LLC (TRC) | 14,627 | $23,000 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 73,800 | $115,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 65 | $0 | 0.00% |
| NORTHERN TRUST CORP | 16,703 | $26,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 37,944 | $59,000 | 0.00% |
| STATE STREET CORP | 45,200 | $71,000 | 0.00% |
| MORGAN STANLEY | 93,973 | $147,000 | 0.00% |
| BlackRock Inc. | 75,948 | $118,000 | 0.00% |